IGFBP4 Antikörper (AA 180-229)
-
- Target Alle IGFBP4 Antikörper anzeigen
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Bindungsspezifität
- AA 180-229
-
Reaktivität
- Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schaf, Ziege, Fledermaus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGFBP4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human IGFBP4
- Homologie
- Percent identity by BLAST analysis: Human, Mouse, Sheep, Dog, Bovine, Horse (100%) Pig, Guinea pig, Chicken (92%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa180-229 of human IGFBP4 (P22692, NP_001543). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Mouse, Rat, Sheep, Goat, Elephant, Panda, Dog, Bovine, Bat, Rabbit, Horse (100%), Marmoset, Hamster, Pig, Guinea pig, Turkey, Zebra finch, Chicken, Lizard (92%), Opossum (85%).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product IGFBP4 Primärantikörper
-
-
- Applikationshinweise
-
Approved: IHC, IHC-P (5 μg/mL), WB (1 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:62500. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Andere Bezeichnung
- IGFBP4 / IGFBP-4 (IGFBP4 Produkte)
- Synonyme
- IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper
- Hintergrund
-
Name/Gene ID: IGFBP4
Synonyms: IGFBP4, BP-4, HT29-IGFBP, IGF-binding protein 4, IBP-4, IGFBP-4, IBP4 - Gen-ID
- 3487
- NCBI Accession
- NP_001543
- UniProt
- P22692
- Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-